CANF

Can-Fite BioPharma

9 hedge funds and large institutions have $2.66M invested in Can-Fite BioPharma in 2015 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.

Holders
9
Holders Change
-2
Holders Change %
-18.18%
% of All Funds
0.24%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
3
Increased
4
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
TAM
1
Taylor Asset Management
Ontario, Canada
$1.66M 568,000 +81,500 +17%
Morgan Stanley
2
Morgan Stanley
New York
$705K 241,586 +157,826 +188%
MC
3
Menta Capital
California
$113K 38,800 +26,600 +218%
Jane Street
4
Jane Street
New York
$108K 37,051 -105,879 -74%
VKH
5
Virtu KCG Holdings
New York
$52K 17,826 +3,068 +21%
Creative Planning
6
Creative Planning
Kansas
$14K 4,900 +4,900 New
Group One Trading
7
Group One Trading
Illinois
$6K 2,048 +2,048 New
IA
8
IFP Advisors
Florida
$4K 1,500 +1,500 New
MFS
9
MSI Financial Services
Massachusetts
$3K 1,000
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
-13,953 Closed
BG
11
Bollard Group
Massachusetts
-7,686 Closed
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
-6,000 Closed
Citigroup
13
Citigroup
New York
-3,954 Closed
TRCT
14
Tower Research Capital (TRC)
New York
-69 Closed